Welcome to our dedicated page for MARSH & MCLENNAN COMPANIES SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MARSH & MCLENNAN COMPANIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MARSH & MCLENNAN COMPANIES's regulatory disclosures and financial reporting.
South Martin reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies’ Chief Client Officer South Martin received a grant of 5,963 restricted stock units. These units represent the right to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis, subject to vesting conditions.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029. This is a compensation-related award rather than an open-market stock purchase or sale, and after this grant Martin holds 5,963 restricted stock units directly.
MCGIVNEY MARK C reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies executive Mark C. McGivney received a grant of 59,627 restricted stock units. These units were awarded as compensation and are convertible into an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, 2028, and 2029, subject to continued service and any plan terms. Following this grant, McGivney holds 59,627 restricted stock units directly, with no open-market buying or selling reported in this filing.
MARSH & MCLENNAN COMPANIES, INC. reported that executive Nicholas Mark Studer, President and CEO of Marsh Risk, received a grant of 8,945 restricted stock units (RSUs) on Marsh & McLennan common stock as equity-based compensation.
The RSUs convert into common stock on a 1-for-1 basis and are scheduled to vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this award, Studer holds a total of 14,711 RSUs directly. This is a compensation-related grant, not an open-market share purchase or sale.
Marsh & McLennan Companies President and CEO John Q. Doyle received a grant of 89,441 restricted stock units as equity compensation. These units convert into common stock on a 1-for-1 basis and vest in three equal annual installments on May 15, 2027, 2028, and 2029.
Marsh & McLennan Companies reported that Patrick Tomlinson, President and CEO of Mercer, received a grant of 14,907 restricted stock units. These units convert into Marsh & McLennan common stock on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this grant, Tomlinson holds 19,761 restricted stock units directly.
MARSH & MCLENNAN COMPANIES, INC. reported that SVP and Chief People Officer Carmen Fernandez received a grant of 5,963 restricted stock units.
The units convert into common stock on a 1-for-1 basis and vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this grant, she holds 5,963 restricted stock units directly.
Brennan Katherine reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. reported that SVP and General Counsel Katherine Brennan received a grant of 5,963 Restricted Stock Units. Each unit is convertible into one share of Marsh & McLennan common stock on a 1-for-1 basis.
The RSUs vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029, tying the award to multi-year service and performance with the company.
Marsh & McLennan Cos Inc ownership filing: Vanguard Capital Management reported beneficial ownership of 36,418,783 shares of Common Stock, representing 7.52% of the class as of 03/31/2026. The filing lists sole voting power of 4,951,109 shares and sole dispositive power for 36,418,783 shares. The Schedule 13G was signed on 04/30/2026.
Marsh & McLennan Companies reported lower profitability for the quarter ended March 31, 2026, despite higher revenue. Revenue rose to $7.60 billion from $7.06 billion, driven by both Risk & Insurance Services and Consulting.
Operating income declined to $1.75 billion from $2.01 billion, largely due to a $425 million legal liability and related costs recorded in Risk & Insurance Services for Greensill-related proceedings in Australia. Net income attributable to the company fell to $1.15 billion, with diluted EPS down to $2.36 from $2.79.
Operating cash flow was a $688 million outflow, reflecting seasonal working capital movements and compensation payments. The company continued returning capital, repurchasing 4.2 million shares for $750 million and declaring dividends of $1.80 per share for the period, while restructuring under its three‑year “Thrive” program added $45 million of charges.
Marsh & McLennan Companies reported solid first quarter 2026 results with continued growth in its core businesses but a notable legal charge affecting GAAP earnings.
Revenue reached $7.6 billion, up 8% from the first quarter of 2025, or 4% on an underlying basis after adjusting for currency and deal effects. Risk & Insurance Services revenue rose 6% to $5.1 billion, while Consulting revenue increased 11% to $2.6 billion, both showing mid‑single‑digit underlying growth.
GAAP operating income declined 12% to $1.8 billion, driven by a $425 million charge related to the Greensill litigation. Excluding this and other noteworthy items and intangible amortization, adjusted operating income increased 8% to $2.4 billion, with an adjusted operating margin of 31.8%.
Net income attributable to the company was $1.1 billion, with diluted GAAP EPS of $2.36 versus $2.79 a year earlier. Adjusted EPS rose 8% to $3.29 from $3.06, reflecting underlying earnings growth despite the litigation charge.
The company continued capital returns, repurchasing approximately 4.2 million shares for $750 million and paying dividends. It also issued and repaid $600 million of senior notes. Management highlighted stable growth across geographies and segments, including 5% underlying revenue growth in International Marsh Risk and 5% underlying growth at Mercer.